BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31792355)

  • 1. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications.
    Lee CH; Su SY; Sittampalam K; Chen PC; Petersson F; Kao YC; Carpenter TO; Hsieh TH; Konishi E; Tsai JW; Billings SD; Folpe AL; Lee JC
    Mod Pathol; 2020 May; 33(5):858-870. PubMed ID: 31792355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and Sinonasal Tract.
    Lee JC; Hsieh TH; Kao YC; Tsai CF; Huang HY; Shih CY; Song HL; Oda Y; Chih-Hsueh Chen P; Pan CC; Sittampalam K; Petersson F; Konishi E; Chiu WY; Chen CF; Carpenter TO; Lu TP; Chang CD; Huang SC; Folpe AL
    Mod Pathol; 2023 Dec; 36(12):100336. PubMed ID: 37742927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.
    Lee JC; Su SY; Changou CA; Yang RS; Tsai KS; Collins MT; Orwoll ES; Lin CY; Chen SH; Shih SR; Lee CH; Oda Y; Billings SD; Li CF; Nielsen GP; Konishi E; Petersson F; Carpenter TO; Sittampalam K; Huang HY; Folpe AL
    Mod Pathol; 2016 Nov; 29(11):1335-1346. PubMed ID: 27443518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
    Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
    Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.
    Tajima S; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(8):9422-7. PubMed ID: 26464698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.
    Lee JC; Jeng YM; Su SY; Wu CT; Tsai KS; Lee CH; Lin CY; Carter JM; Huang JW; Chen SH; Shih SR; Mariño-Enríquez A; Chen CC; Folpe AL; Chang YL; Liang CW
    J Pathol; 2015 Mar; 235(4):539-45. PubMed ID: 25319834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA Sequencing Reveals Novel Oncogenic Fusions and Depicts Detailed Fusion Transcripts of FN1-FGFR1 in Phosphaturic Mesenchymal Tumors.
    Liu X; Yin X; Li D; Li K; Zhang H; Lu J; Zhou L; Gao J; Wang J; Wu H; Liang Z
    Mod Pathol; 2023 Oct; 36(10):100266. PubMed ID: 37391169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
    Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
    Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.
    Mok Y; Lee JC; Lum JH; Petersson F
    Histopathology; 2016 May; 68(6):925-30. PubMed ID: 26407099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Novel NIPBL-BEND2 fusion gene identified in osteoblastoma-like phosphaturic mesenchymal tumor of the fibula.
    Sakai T; Okuno Y; Murakami N; Shimoyama Y; Imagama S; Nishida Y
    Front Oncol; 2022; 12():956472. PubMed ID: 36686800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
    Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
    Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
    Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
    Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
    Amary F; Perez-Casanova L; Ye H; Cottone L; Strobl AC; Cool P; Miranda E; Berisha F; Aston W; Rocha M; O'Donnell P; Pillay N; Tirabosco R; Baumhoer D; Hookway ES; Flanagan AM
    Mod Pathol; 2019 Dec; 32(12):1762-1771. PubMed ID: 31273315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-induced osteomalacia.
    Florenzano P; Gafni RI; Collins MT
    Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphaturic mesenchymal tumors: what an endocrinologist should know.
    Boland JM; Tebben PJ; Folpe AL
    J Endocrinol Invest; 2018 Oct; 41(10):1173-1184. PubMed ID: 29446010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis.
    Liu YJ; Wang W; Yeh J; Wu Y; Mantilla JG; Fletcher CDM; Ricciotti RW; Chen EY
    Mod Pathol; 2021 Jul; 34(7):1373-1383. PubMed ID: 33727696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Klotho causes hypomineralization in Klotho-deficient mice.
    Minamizaki T; Konishi Y; Sakurai K; Yoshioka H; Aubin JE; Kozai K; Yoshiko Y
    J Endocrinol; 2018 Jun; 237(3):285-300. PubMed ID: 29632215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphaturic mesenchymal tumors: A review and update.
    Folpe AL
    Semin Diagn Pathol; 2019 Jul; 36(4):260-268. PubMed ID: 31301876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur.
    Ren D; Wei K; Ifegwu I
    Am J Case Rep; 2024 Feb; 25():e942810. PubMed ID: 38361352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
    Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
    Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.